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A comparison of the effects of intrathecal ropivacaine and
bupivacaine during cesarean section*
Nuray CAMGÖZ ERYILMAZ1, Berrin GÜNAYDIN2

Aim: To compare the effects of intrathecal plain bupivacaine or ropivacaine with those of opioids on sensory and motor
block characteristics during cesarean section (C/S).
Materials and methods: Fifty-two ASA I or II women were randomly allocated into 2 groups to administer either 10
mg of 0.5% plain bupivacaine (Group B), or 15 mg of 0.75% plain ropivacaine (Group R) with 25 μg fentanyl and 100 μg
morphine for spinal anesthesia. Characteristics of the sensory and motor block were recorded.
Results: The time to achieve sensory block at T6 was significantly faster in Group B than in Group R (2.7 ± 1.8 min
vs. 4.2 ± 2.5 min). The time to reach maximum sensory block was significantly faster in Group B than in Group R
(8.1 ± 4.1 min vs. 11.6 ± 5.6 min). The times of sensory block regression to T10 and L1 dermatomes were significantly
shorter in Group B (118.2 ± 24.2 min and 145.5 ± 28.1 min, respectively) than in Group R (135 ± 32.1 min and
162.5 ± 32.5 min, respectively). Motor block duration was significantly longer in Group B than in Group R (165.8
± 32.5 min vs. 135.2 ± 45.7 min).
Conclusion: Intrathecal plain ropivacaine with opioids might be superior to bupivacaine in terms of a longer sensory
block, and a shorter motor block duration for C/S.
Key words: Surgery, Cesarean section, anesthetic technique, spinal, local anesthetics, bupivacaine, ropivacaine

Sezaryenlerde intratekal ropivakain ve bupivakainin etkilerinin karşılaştırılması
Amaç: Sezaryenlerde intratekal izobarik ropivakain ve bupivakain ile opioidlerin motor ve duyusal blok özelliklerine
etkilerinin karşılaştırılması amaçlandı.
Yöntem ve gereç: Elli iki gebe spinal anestezi için 25 μg fentanil + 100 μg morfin ile % 0,5 izobarik bupivakain 10 mg
(Grup B) veya % 0,75 izobarik ropivakain 15 mg (Grup R) vermek üzere rastgele iki gruba ayrıldı. Duyusal ve motor
blok özellikleri kaydedildi.
Bulgular: T6’da duyusal blok elde etme zamanı Grup B’de Grup R’den anlamlı olarak hızlıydı (2,7 ± 1,8 ile 4,2 ± 2,5
dk). Maksimum duyusal blok seviyesine ulaşma süresi Grup B’de Grup R’den hızlı bulundu (8,1 ± 4,1 ile 11,6 ± 5,6
dk). Grup B’de T10 ve L1 dermatomlarına gerileme süreleri (118,2 ± 24,2 ile 145,5 ± 28,1 dk, sırasıyla) Grup R’den
daha kısaydı (135 ± 32,1 ile 162,5 ± 32,5 dk, sırasıyla). Motor blok süresi Grup B’de Grup R’den daha uzundu (165,8
± 32,5 ile 135,2 ± 45,7 dk).
Sonuç: İntratekal izobarik ropivakain ile opioidler daha uzun duyusal blok ve daha kısa motor blok süresiyle sezaryenler
için bupivakainden üstün olabilir.
Anahtar sözcükler: Cerrahi, sezaryen, anestezi tekniği, spinal, lokal anestezik, bupivakain, ropivakain
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Introduction
Single shot spinal anesthesia is now the most
commonly used anesthetic technique for cesarean
delivery (1). Although the local anesthetic of choice
is typically bupivacaine in obstetric anesthesia
practice, ropivacaine, which has gained increased
popularity due to its lower motor block effect, rather
than bupivacaine has been used for spinal anesthesia
during elective cesarean delivery (2-4).
The spread of the block is thought be influenced
by the mass of the local anesthetic rather than the
concentration or volume, as well as factors such as
the coadministration of neuraxial opioids. Thereby,
the combination of intrathecal local anesthetics with
opioids provides a high quality sensory block with
optimal pain control, and decreases the incidence of
adverse effects related to local anesthetics (1). When
intrathecal bupivacaine and ropivacaine, combined
with 10 μg fentanyl and 200 μg morphine, were
used for cesarean sections, the median effective dose
50% of recipients (ED50) and ED95 of 0.5% isobaric
bupivacaine were 7.25 mg and 13 mg, respectively,
whereas ED50 and ED95 of isobaric ropivacaine were
16.7 mg, and 26.8 mg, respectively (3,5). However,
the equipotent doses of intrathecal ropivacaine and
bupivacaine are still controversial (6,7). Therefore,
this study aimed to compare the effects of intrathecal
plain bupivacaine or ropivacaine with fentanyl and
morphine on maternal hemodynamic parameters,
the amount of ephedrine used, the sensory and motor
block characteristics, Apgar scores, and the side
effects in parturients scheduled to undergo cesarean
section (C/S) under spinal anesthesia.
Materials and methods
After obtaining the approval of the institutional
ethics committee and written informed consent
from each patient, the 52 American Society of
Anesthesiologists (ASA) physical status I or II,
term parturients with weight under 100 kg and
height between 150 cm and 180 cm, scheduled to
undergo elective C/S under spinal anesthesia, were
enrolled in the study. Parturients having psychiatric,
neurologic, cardiac, hematologic disease, diabetes,
multiple gestation, preeclampsia, eclampsia, bleeding
or coagulation disorder, gestational age smaller than
220

37 weeks, or fetal compromise or contraindication to
spinal anesthesia were not included in this study.
All women were fasted overnight and received
ranitidine 50 mg intravenous (IV), half an hour
before the spinal anesthesia. After routine infusion
of lactated Ringer’s solution (10 mL/kg), spinal
anesthesia was performed with a 27 G Whitacre
spinal needle (B-Braun, Melsungen) using the
midline approach between the L3-4 intervertebral
space in the sitting position.
According to computer generated random group
names as B or R enclosed, parturients were randomly
allocated into 2 groups to receive either intrathecal
plain bupivacaine (Group B), or ropivacaine (Group
R). Two milliliters of 0.5% plain bupivacaine 10 mg
(Marcaine® 0.5%, 20 mL flacon, Astra Zeneca) in
Group B, and 2 mL of 0.75% isobaric ropivacaine
15 mg (Naropin® 7.5 mg/mL, 10 mL injection, Astra
Zeneca) in Group R were combined with 25 μg
fentanyl plus 100 μg morphine. The total volume of
solutions in each group was 3 mL.
The study drug solutions were prepared by one of
the anesthesiologist who did not perform the spinal
block, and was not involved in data collection. The
other anesthesiologist performed the spinal block,
and collected pre- and postoperative data. After
observing the free flow of cerebrospinal fluid (CSF),
spinal anesthesia was induced by injecting 1 of these 2
solutions over 30 s. Thereafter, the patient was turned
to supine with left uterine displacement provided by
tilting the operation table approximately 15° to the
left. Afterwards, a urinary catheter was placed.
Hemodynamic parameters like heart-rate
(HR), ECG, noninvasive blood pressure (BP), and
peripheral oxygen saturation (SpO2) were measured
every 2 min during the first 10 min after performing
the spinal block, then every 5 min in the first h, and
every 10 min until the patient moved to the recovery
unit. Hypotension was defined as ³ 20% decrease
from baseline mean blood pressure (MBP) and
treated with IV ephedrine of 10 mg. The amount of
ephedrine used was recorded. A grading was used
to assess nausea (0 = none, 1 = nausea, 2 = retching,
3 = vomiting) and if nausea was not related to
hypotension, it was treated with metoclopramide 10
mg IV.
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The level of sensory block was evaluated by
loss of pinprick sensation using the short beveled
end of a needle with a blunt tip, and the absence of
cold sensation from an alcoholic swab at the midclavicular level bilaterally every 2 min during the first
10 min, every 5 min during the first hour, every 10
min until discharged from the recovery unit, then
every 15 min until the regression of the sensory block
to L1. The motor block was assessed immediately
after the sensory block assessment using a modified
Bromage scale (0 = no paralysis, 1 = unable to raise
extended leg, 2 = unable to flex knee, 3 = complete
paralysis) every 2 min during the first 10 min, every
5 min during the first hour, and every 10 min until
complete recovery.
The induction of spinal anesthesia was
considered successful when at least the T6
dermatome was anesthetized. The duration of the
surgery, the amount of time to achieve sensory
block at T6, the maximum cephalad spread of
the sensory block, the time of the sensory block
to regress to T10 and L1, the amount of time to
achieve the maximum motor block, the duration
of motor block, the first analgesic requirement
(duration of analgesia), Apgar scores (1 min and
5 min), and the incidence of maternal side effects
were all noted. The satisfaction rates of patients
and surgeons from the anesthesia regimen were
assessed as “very good”, “good”, “moderate”, “bad”,
or “very bad” on the first postoperative day.
The surgery was allowed to start when the sensory
block reached T4. The surgical technique was
uniform, including exteriorization of the uterus, for
all patients. Oxytocin 20 IU in 1000 mL of lactated
Ringer’s solution was administered by infusion after
delivery. After recording the time of first analgesic
request of the patient, intravenous tenoxicam 20 mg,
and/or paracetamol 1 g were used for postoperative
analgesia.

gestation age (week), newborn weight, the duration of
the operation, upper sensory block level, the time to
reach the maximum sensory block, the time to achieve
sensory block at T6, the sensory block regression
time to T10 and L1 dermatomes, and the duration
of motor block were analyzed using Mann-Whitney
U test between the groups. Data regarding newborn
Apgar scores (1 min and 5 min), motor block degree,
ephedrine requirement, satisfaction rate of patients
and surgeons, and side effects were compared using
a chi square test between the groups. Heart rate,
mean blood pressure, peripheral oxygen saturation,
and motor block data within the dependent groups
and between the independent groups were compared
with Wilcoxon signed rank test and Mann-Whitney
U test, respectively. A P value of less than 0.05 was
considered significant.
Results
There were no significant differences in the
demographic properties of the parturients or the
duration of the surgery between the groups (Table 1).
The times to achieve sensory block at T6 and the
maximum sensory block were significantly shorter
with intrathecal plain bupivacaine than those with
intrathecal plain ropivacaine (Group B: 2.7 ± 1.8 min
vs. Group R: 4.2 ± 2.5 min, and Group B: 8.1 ± 4.1
min vs. Group R: 11.6 ± 5.6 min, respectively) (P <
0.05). The times of the sensory block regression to
T10 and L1 dermatomes were significantly shorter in
Group B (118.2 ± 24.2 min, and 145.5 ± 28.1 min,
respectively) than in Group R (135 ± 32.1 min and
162.5 ± 32.5 min, respectively) (P < 0.05). The motor
block duration was significantly longer in Group B
Table 1. Demographic properties and duration of surgery
(mean ± SD).
Group B
(n = 26)

Group R
(n = 26)

Age (year)

31.3 ± 4.5

32.1 ± 4.5

Height (cm)

161.8 ± 6.1

162.2 ± 5.1

Weight (kg)

75.7 ± 10.8

78.1 ± 9.2

Gestational age (week)

38.5 ± 0.7

38.7 ± 0.6

Duration of surgery (min)

35.2 ± 12.0

31.6 ± 8.4

Statistical analysis
When 26 subjects per group were enrolled, the
power analysis revealed an 80% power and type
I error of 0.05 using PASS/NCSS-2000 Package
Program. Results were expressed as n, median
(range), frequency (%), or mean ± standard deviation
(mean ± SD) where appropriate. After descriptive
statistics, data including maternal demographics,
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(165.8 ± 32.5 min) than in Group R (135.2 ± 45.7
min) (Table 2) (P < 0.05).
Although the time to achieve sensory block at T6
was significantly slower with intrathecal ropivacaine,
both local anesthetics provided adequate block
quality for surgery. The median sensory block values
that were evaluated at 2 min, 4 min, and 6 min after
the spinal block in Group B were significantly higher
than in Group R (Figure 1).

Regarding hemodynamic parameters of the
parturients, the mean HR values were comparable
between the groups (Figure 2). As for MBP, significant
reductions, with respect to baseline measurements,
were observed between 4 min and 10 min after the
spinal block in both groups. When the 2 groups were
compared, the MBP decreased significantly 10 min
and 20 min after the spinal block in the ropivacaine
group when compared to the bupivacaine group
(Figure 3).

Complete motor block occurred in both groups,
except for in one patient in Group R. The median
degree of motor block was higher at 2 min, 4 min,
6 min, 10 min, and 15 min after the spinal block in
Group B with respect to Group R according to the
Bromage scale (Table 3).

There were no significant differences in the
ephedrine requirement, the duration of analgesia or
the first analgesic requirement, mobilization time,
or the onset of intestinal activity between the groups
(Table 5).

No significant differences were found in Apgar
scores (1 min and 5 min), and the incidence of preand postoperative side effects between the groups
(Table 4).

The satisfaction rate of patients was comparable
between the groups. However, the satisfaction rate of
surgeons as “very good” was significantly higher in
Group B than in Group R (P < 0.05) (Table 6).

Table 2. Sensory and motor block characteristics (mean ± SD).
Group B (n = 26)

Group R (n = 26)

T 3 (T6-T1 )

T 3 (T6-T1 )

Time to reach maximum sensory block (min)

8.1 ± 4.1*

11.6 ± 5.6

Time to achieve sensory block at T6 (min)

2.7 ± 1.8*

4.2 ± 2.5

Sensory block regression time to T10 dermatome (min)

118.2 ± 24.2*

135 ± 32.1

Sensory block regression time to L1 dermatome (min)

145.5 ± 28.1*

162.5 ± 32.5

Duration of motor block (min)

165.8 ± 32.5*

135.2 ± 45.7

Upper sensory block level (dermatome)

Thoracal dermatoms

*P < 0.05 between the groups
12
11
10
9
*
8
*
7
6
5
4
3
2
1
0
Baseline 2 4

*

GROUP B

6

8

GROUP R

10 15 20 25 30 35 40 45 50 55 60 End
Time intervals (min)

Figure 1. Sensory block versus time. *P < 0.05 between the groups.
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Table 3. Motor block degree versus time [(median) (range)].
Group B (n = 26)

Group R (n = 26)

0

0

2 (1-3)*

1 (0-3)

4 min

2 (1-3)*

2 (0-3)

6 min

2.5 (2-3)*

2 (0-3)

8 min

3 (2-3)

2.5 (1-3)

10 min

3 (2-3)*

3 (1-3)

15 min

3 (3-3)*

3 (2-3)

20 min

3 (3-3)

3 (2-3)

25 min

3 (3-3)

3 (2-3)

30 min

3 (3-3)

3 (2-3)

35 min

3 (3-3)

3 (2-3)

40 min

3 (3-3)

3 (2-3)

45 min

3 (3-3)

3 (2-3)

50 min

3 (3-3)

3 (2-3)

55 min

3 (3-3)

3 (2-3)

60 min

3 (3-3)

3 (2-3)

3

3 (3-3)

Baseline
2 min

End of the operation
*P < 0.05 (between the groups)

Table 4. Apgar scores (median), incidence of preoperative (preop.) and postoperative
(postop.) side effects (n).
Group B (n = 26)

Group R (n = 26)

Apgar 1 min / 5 min (median)

9/10

9/10

Preop./Postop. Nausea (n)

12/6

10/6

Preop./Postop. Vomiting (n)

5/3

2/3

Preop./Postop. Itching (n)

5/13

4/17

0

0

Postspinal Headache (n)

Discussion
It was demonstrated that the significantly faster
onset and regression of sensory block resulted
in significantly higher surgeon satisfaction with
intrathecal bupivacaine and opioids, however, a
significantly shorter motor block duration with
intrathecal plain ropivacaine, fentanyl, and morphine
might be advantageous for elective C/S under spinal
anesthesia, because it allowed a faster discharge, and/
or early recognition of neurologic complications in
the present study.

The comparison of intrathecal plain ropivacaine
versus plain bupivacaine has been studied in nonobstetric and obstetric surgery under spinal anesthesia
(2,4,6-8). Intrathecal 15 mg of ropivacaine provided
faster motor block recovery, and the duration of
sensory block was similar when compared to 10 mg of
bupivacaine during minor lower extremity surgery (7).
The cephalad spread of sensory block was higher with
intrathecal 10 mg of bupivacaine than with intrathecal
15 mg of ropivacaine, but the onset of anesthesia at
T10, which was adequate for transurethral resection of
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HR (beat/min)

Group B
120
110
100
90
80
70
60
50
40
30
20
10
0
Baseline

2

4

6

Group R

8

10

15

20

30

End of the
operation

Time intervals (min)

Time intervals (min)

End of the
operation

10

*

30

+ *
+

20

+ +

15

+ +

8

4

+ +

2

120
100
80
60
40
20
0

Group R

6

Group B

Baseline

Mean Blood Pressure (mmHg)

Figure 2. Heart rate (HR) versus time.

Figure 3. Mean blood pressure (MBP) versus time.

Table 5. Ephedrine requirement, duration of analgesia (first analgesic requirement
time), and mobilization time (mean ± SD).
Group B (n = 26)

Group R (n = 26)

23.7 ± 14.1

28.3 ± 19.0

348.1 ± 246.7

437.0 ± 222.6

Mobilization time (h)

12.0 ± 4.8

9.8 ± 2.9

Onset of intestinal activity (h)

20.7 ± 5.3

21.8 ± 4.7

Ephedrine requirement (mg)
Analgesia duration (min)

Table 6. Satisfaction rate of patients and surgeons (n).
Satisfaction Rate

Very good

Good

Moderate

Bad

Very bad

Group B

14 (53.8)

11 (42.3)

1 (3.8)

0 (0)

0 (0)

Group R

16 (61.5)

10 (38.5)

0 (0)

0 (0)

0 (0)

Patient

Surgeon
Group B

18 (69.2)*

8 (30.8)

0 (0)

0 (0)

0 (0)

Group R

11 (42.3)

14 (53.8)

1 (3.8)

0 (0)

0 (0)

*P < 0.05 between the groups
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prostate (TUR), was comparable between ropivacaine
and bupivacaine (8). Since these 2 studies have not
been done in the obstetric population, and intrathecal
opioids have not been added to local anesthetics, it
is not appropriate to compare them with our present
results. However, several studies have been done in the
obstetric population comparing block characteristics
of intrathecal plain ropivacaine and bupivacaine with
morphine and/or sufentanil during C/S. Therefore,
our study has been the first to demonstrate the
comparative effects of intrathecal plain ropivacaine,
and bupivacaine coadministered with both fentanyl
and morphine.
According to the study by Gautier et al. (4), when
intrathecal bupivacaine 8 mg or ropivacaine 12 mg
was coadministered with intrathecal sufentanil, the
time to reach maximum cephalad spread, and the
time of regression to T10 was comparable between
bupivacaine and ropivacaine, but the duration of
motor block and the first analgesic requirement
were significantly shorter with ropivacaine (4). In
contrast to that study, it was found that the time to
reach maximum cephalad spread and the amount of
time to regression to T10 were significantly shorter
with bupivacaine 10 mg than ropivacaine 15 mg, but
the first analgesic requirement was similar between
ropivacaine and bupivacaine groups in the present
study. The only similar finding was the duration of
motor block, which was significantly shorter with
ropivacaine. The diversity in these results could be
due to the different intrathecal dose used, and the
different opioid added, with respect to our study.
In another study, although higher intrathecal
doses of bupivacaine, and ropivacaine (15 mg of
each local anesthetic) with a morphine addition
were used, the time to reach the maximum sensory
block level and 2 segment regression times were
similar; however, the duration of motor block and the
amount of ephedrine used were significantly less with
ropivacaine than with bupivacaine (2). These results
were also different than ours, because the same doses
of local anesthetics were used, though a potency ratio
of 0.6 has been described by Polley et al. between
bupivacaine and ropivacaine in 1999 (9). Therefore,
we selected bupivacaine 10 mg versus ropivacaine 15
mg based on that potency ratio of 0.6, in order to make
a valid and relevant comparison. We demonstrated

that an intrathecal equipotent dose of bupivacaine
and ropivacaine plus opioids provided satisfactory
surgical anesthesia and postoperative properties,
including similar analgesia duration, mobilization
time, and the onset of intestinal activity. Although the
sensory and motor block characteristics significantly
varied between bupivacaine and ropivacaine, both
local anesthetics did not result in significant changes
in the ephedrine requirement.
Intrathecal 10 mg of plain bupivacaine resulted
in the higher cephalad spread of sensory block than
that of intrathecal 15 mg of plain ropivacaine (T4
versus T6) during spinal anesthesia for TUR (8). In
contrast to that study, the mean maximum sensory
block level was found to be T3 with both local
anesthetics, though the time to achieve sensory block
at T6 was significantly shorter with bupivacaine than
ropivacaine in the present study.
The motor blocking potencies of intrathecal
local anesthetics in parturients undergoing elective
cesarean delivery with combined spinal-epidural
(CSE) anesthesia have been investigated (10,11).
The median effective dose (ED50) for motor block
with intrathecal ropivacaine, levobupivacaine,
and bupivacaine were 5.79 mg, 4.83 mg, and 3.44
mg, respectively (11). In the present study, spinal
anesthesia was preferred instead of CSE, using 10
mg of plain bupivacaine and 15 mg ropivacaine both
with fentanyl and morphine according to previously
determined ED95 for each local anesthetic, as well as
the potency ratio between them. We observed a motor
block degree of 2 (corresponding unable to flex knee)
occurred 2 min after the spinal block and reached 3
(corresponding to complete paralysis) within 10 min
after the spinal block with intrathecal bupivacaine.
The median motor block degree due to intrathecal
bupivacaine was significantly higher than intrathecal
ropivacaine, between 2 min and 15 min following the
spinal block. Similarly, results of the present study
also demonstrated that intrathecal bupivacaine and
ropivacaine displayed a high and low clinical profile
of potency for motor block, respectively.
There were significant reductions with respect to
baseline measurements in MBP between 4 min and
10 min after the spinal block in both groups and
parturients were treated with ephedrine. Although
the MBP significantly decreased with ropivacaine
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rather than with bupivacaine 10 min and 20 min
after the spinal block, they were within clinically
acceptable limits. Ultimately, we did not find any
significant difference in the amount of ephedrine
used between the groups.
In conclusion, even though intrathecal plain
bupivacaine with fentanyl and morphine provided
a faster sensory block onset and a regression with
a longer motor block duration than that with

ropivacaine, the hemodynamic deterioration in
blood pressure requiring vasopressor treatment was
similar. Therefore, intrathecal plain ropivacaine with
fentanyl and morphine might be superior for cesarean
delivery, because of a longer sensory block regression
with a shorter time of motor block duration allowing
the recognition, if any, of possible neurological
complications as early as possible in busy labor units
where early patient discharge is required.
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